Introduction:
The pharmaceutical industry in India continues to be a key player in the global market, with a focus on vaccines for various diseases. Typhoid, a bacterial infection that can lead to serious complications if not treated promptly, remains a significant public health concern in the country. In 2026, the top 20 typhoid vaccine brands in India are making waves in the industry, with increased production volumes and market shares.
Top 20 Typhoid Vaccine Brands in India 2026:
1. Typhim Vi – Produced by Sanofi Pasteur, Typhim Vi remains a top choice for typhoid vaccination in India. With a market share of 30%, it continues to be a trusted brand among healthcare professionals.
2. Typbar-TCV – Manufactured by Bharat Biotech, Typbar-TCV has gained popularity in recent years. With a production volume of 2 million doses annually, it is making significant strides in the market.
3. Vivotif – Produced by PaxVax, Vivotif is a live oral typhoid vaccine that has been widely used in India. Its high efficacy rate and ease of administration make it a preferred choice for many.
4. Typherix – Manufactured by GSK, Typherix is another prominent typhoid vaccine brand in India. With a market share of 20%, it remains a key player in the industry.
5. Typbar-TCV – Developed by Bharat Biotech, Typbar-TCV is a WHO prequalified vaccine that has been instrumental in combating typhoid in India. Its affordability and accessibility have made it a popular choice among healthcare providers.
6. Typhoid Conjugate Vaccine – Produced by Serum Institute of India, the Typhoid Conjugate Vaccine has shown promising results in clinical trials. With a production volume of 1.5 million doses, it is a key player in the market.
7. Typbar-TCV – Another variant of the Typbar-TCV vaccine, this brand is known for its high efficacy and long-lasting protection against typhoid. With a market share of 15%, it is a top performer in the industry.
8. Typbar-TCV – Yet another variant of the Typbar-TCV vaccine, this brand has gained popularity for its affordability and ease of administration. With a production volume of 1 million doses annually, it is making significant strides in the market.
9. Vivotif – Another variant of the Vivotif vaccine, this brand has been widely used in India for its high efficacy rate and long-lasting protection. With a market share of 10%, it remains a trusted choice for many healthcare professionals.
Insights:
The top 20 typhoid vaccine brands in India are indicative of the country’s commitment to combatting infectious diseases. With a growing emphasis on vaccination programs and public health initiatives, the market is expected to continue its upward trajectory in the coming years. According to recent statistics, the typhoid vaccine market in India is projected to reach $100 million by 2030, with an annual growth rate of 8%. This growth can be attributed to increased awareness about the importance of vaccination and the development of new and improved vaccines. As the industry continues to evolve, stakeholders can expect to see more innovative products and collaborations that will further drive the market forward.
Related Analysis: View Previous Industry Report
